MedVector CorpAmended

Biotechnology · El Segundo, CA

BiotechnologySEC Form D

MedVector Corp filed a Form D with the U.S. Securities and Exchange Commission on May 6, 2026, reporting $1,005,000 raised toward a $1,100,000 offering.

Incorporated in Delaware and based in El Segundo, CA, it operates in the Biotechnology sector.

Companies file a Form D within 15 days of the first sale of securities in a private offering under Regulation D — an early, public signal that MedVector Corp has raised capital from private investors.

Browse more recently funded companies in Biotechnology.

Executives & Directors

  • Ted BardusonExecutive Officer · Director · Promoter
  • Scott StoutExecutive Officer · Director · Promoter
  • Ian LeamanExecutive Officer · Director · Promoter
  • Dennis PattersonDirector
  • Craig LipsetDirector

Recently funded in Biotechnology

Other companies that recently filed a Form D

$3.2MRaised

Goldenrod Therapeutics, Inc.

BiotechnologyHOUSTON, TX
$10.0MRaised

Human Biotech, Inc.

BiotechnologyCAMBRIDGE, MA
$1.0MRaised

Optimeos Life Sciences, Inc.

BiotechnologyPRINCETON, NJ
$2.5MRaised

BioStem Technologies, Inc.

BiotechnologyPOMPANO BEACH, FL
$1.6MRaised

Biolexis Therapeutics Inc.

BiotechnologyLEHI, UT
MedVector Corp raised $1.0M — SEC Form D